Monday, 8 November 2021

SGLT2 Inhibitors Provide Kidney, Heart Protection

Sodium-glucose cotransporter 2(SGLT2) inhibitors intake was linked to a lower risk of developing cardiovascular disease and kidney failure among patients with type 1 diabetes.


from Medindia Health News https://ift.tt/31DA5rn

No comments:

Post a Comment